AMR NEWS: Your Global Source for the Latest AMR Insights and Publications!

AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.


5 March 2019

CARB-X funds Contrafect to develop a new class of antibiotics to treat serious infections caused by Gram-negative ESKAPE Superbugs
4 March 2019

Silver Nanorods for detection of viability and antibiotic resistance in bacterial strains
1 March 2019

Genetic test to detect antimicrobial resistance developed
27 February 2019

Physicists Pinpoint a Simple Mechanism That Makes Bacteria Resistant to Antibiotics
27 February 2019

CARB-X expands its global accelerator network to support the development of antibiotics, rapid diagnostics and vaccines to combat drug-resistent superbugs
23 February 2019

Identification of a novel hybrid plasmid coproducing MCR-1 and MCR-3 variant from an Escherichia coli strain
23 February 2019

Investigators Figure Out How to Block New Antibiotic Resistance Gene
23 February 2019

Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults
23 February 2019

Physicists Develop New Method to Identify Antibiotic-Resistant Bacteria
19 February 2019

QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens
19 February 2019

The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies
19 February 2019

JPIAMR launches AMR Research Funding Dashboard
18 February 2019

Find New Genomic Insights into Antimicrobial Resistance
18 February 2019

Using the NCBI AMRFinder Tool to Determine Antimicrobial Resistance Genotype-Phenotype Correlations Within a Collection of NARMS Isolates
17 February 2019

Bringing Antimicrobial Susceptibility Testing (AST) to the Community
15 February 2019

The antimicrobial potential of Streptomyces from insect microbiomes
15 February 2019

Bicycle Therapeutics to tackle AMR with government funding
13 February 2019

Better Way of Assessing Bacterial Sensitivity to Antibiotics Could Change How Drugs are Prescribed
11 February 2019

Ultrafast search of all deposited bacterial and viral genomic data
11 February 2019

The web meets genomics: a DNA search engine for microbes
9 February 2019

UK Math Professor Developing Framework to Understand Drug-resistant Diseases
9 February 2019

Letter urges Congressional action to stimulate antibiotic development
7 February 2019

Letter urges Congressional action to stimulate antibiotic development
7 February 2019

FDA Accepts for Review NDA for Merck’s Investigational Combination of Imipenem/Cilastatin and Relebactam, and sNDA for ZERBAXA® (Ceftolozane and Tazobactam)
7 February 2019

CARB-X funds Recida Therapeutics to develop a new class of antibiotics to treat deadly infections caused by Gram negative superbugs
5 February 2019

We can win the war on superbugs but only with the right investment
5 February 2019

Mobidiag Announces Completion of €10m Equity Investment from Autobio Diagnostics
5 February 2019

Microbes Hitched to Insects Provide a Rich Source of New Antibiotics
5 February 2019

Researchers Develop New Approach for Vanquishing Superbugs
5 February 2019

Up to £1m funding awarded to develop bacterial vaccines in global fight against antimicrobial resistance
5 February 2019

CARB-X funds Polyphor to develop a new class of antibiotics to treat serious infections caused by Gram- negative ESKAPE superbugs
4 February 2019

MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases
4 February 2019

Pharma firms to be incentivised to develop new superbug drugs
4 February 2019

New Novodiag® Carbar+ test allows rapid, cost-effective molecular testing for ‘superbacteria’ and associated drug resistance
4 February 2019

Pherecydes Pharma reports successful patient treatment with bacteriophages
4 February 2019

The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?
2 February 2019

It takes two: How biopharma and academia are fighting antimicrobial resistance
29 January 2019

CARB-X provides additional funds for phage lysin to treat Pseudomonas
29 January 2019

Whole Genome Sequencing for Personalized Antibiotic Therapy
29 January 2019

Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
29 January 2019

Whole Genome Sequencing Method May Speed Personalized Treatment Of Drug-Resistant Infections
29 January 2019

HKBU scholars invent world-first multidimensional system for rapid antibiotic resistance testing and analysis
29 January 2019

Genentech Develop Antibiotic Effective Against Gram-Negative Bacteria, With Potential To Lead To New Class Of Antibiotics
29 January 2019

Antibiotic Resistance: The Next Challenges Facing Research
29 January 2019

New AMR strategy revamps drug payment model UK
21 January 2019

Lancet: Analysis of the clinical antibacterial and antituberculosis pipeline
21 January 2019

ReAct: Meet winning teams Innovate4AMR
21 January 2019

Peter Jackson: REVAMP-ing antibiotic funding?
20 January 2019

New antibiotic Ramazol for treatment of Clostridium difficile
19 January 2019

Tim Sandle: Rapid diagnostic device to test bacterial responses to various drug combinations


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!